ITU Unit Action

ZYRTEC

UCB PHARMA, S.A.

ITU Unit Action

Trademark Snap Shot ITU Unit Action
(Table presents the data on ITU Unit Action)

OVERVIEW

SERIAL NUMBER 76679895 FILING DATE 07/25/2007
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY DAHLING, KRISTIN M
L.O. ASSIGNED 113

PUB INFORMATION

RUN DATE 10/01/2008
PUB DATE 11/06/2007
STATUS 606-ABANDONED - NO STATEMENT OF USE FILED
STATUS DATE 07/30/2008
LITERAL MARK ELEMENT ZYRTEC

DATE ABANDONED 07/30/2008 DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) YES 1 (b) YES 1 (b) NO
44D NO 44D NO 44D NO
44E NO 44E NO 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK NO
LITERAL MARK ELEMENT ZYRTEC
MARK DRAWING CODE 5-AN ILLUSTRATION DRAWING WITH WORD(S)/LETTER(S)/NUMBER(S) IN STYLIZED FORM
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 20-OWNER AT PUBLICATION
NAME UCB PHARMA, S.A.
ADDRESS Allee de la Recherche 60
B-1070 Brussels, 
ENTITY 03-CORPORATION
CITIZENSHIP Belgium

GOODS AND SERVICES

INTERNATIONAL CLASS 005
          DESCRIPTION TEXT pharmaceutical preparations, namely, antihistaminic and decongestant agents

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 005 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO
COLORS CLAIMED STATEMENT Color is not claimed as a feature of the mark.
OWNER OF US REG NOS 2024253    2535836    2595408   

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
09/30/2008 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED 014
09/30/2008 ABN6 S ABANDONMENT - NO USE STATEMENT FILED 013
01/29/2008 NOAM O NOTICE OF ALLOWANCE-MAILED 012
11/06/2007 PUBO A PUBLISHED FOR OPPOSITION 011
10/17/2007 NPUB O NOTICE OF PUBLICATION 010
10/01/2007 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED 009
10/01/2007 ALIE A ASSIGNED TO LIE 008
08/31/2007 CNEA F EXAMINER'S AMENDMENT MAILED 007
08/30/2007 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER 006
08/30/2007 XAEC I EXAMINER'S AMENDMENT ENTERED 005
08/30/2007 CNEA R EXAMINERS AMENDMENT -WRITTEN 004
08/24/2007 DOCK D ASSIGNED TO EXAMINER 003
08/03/2007 MAFR O APPLICATION FILING RECEIPT MAILED 002
07/30/2007 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Jake D. Feldman
CORRESPONDENCE ADDRESS JAKE D. FELDMAN
Johnson & Johnson
One Johnson & Johnson Plaza
New Brunswick, NJ 08933-7001
DOMESTIC REPRESENTATIVE Jake D. Feldman

PRIOR OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME UCB PHARMA, S.A.
ADDRESS Allee de la Recherche 60
B-1070 Brussels, 
ENTITY 03-CORPORATION
CITIZENSHIP Belgium

ITU Unit Action [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed